Genomatica is a San Diego-based chemical company that, through biotechnology, develops and commercializes innovative bio-manufacturing processes for the sustainable production of high value chemical products. The company was founded in July 2000 by Christophe Schilling and Bernhard Palsson, two preeminent leaders in bioengineering, and is led by CEO Christopher Gann, a former Dow Chemical senior executive with over 25 years experience.

Genomatica’s robust collection of integrated technologies has been key to establishing the company as the true pioneer in the field of chemical bio-manufacturing. Some of these technologies include: 

• Silicon Lab:
• SimPheny: Proprietary award-winning constraint-based metabolic modeling and simulation system
• Metabolic Model Development: The industry’s preeminent collection of predictive models of microbial metabolism and automated systems that facilitate rapid model development.
• OptKnock Strain Design: powerful proprietary algorithms to couple the production of desired chemical products and growth for highly productive, stable biocatalysts.
• Bio-Pathway Predictor: High throughput system for determining all possible biological and chemical transformation routes to a desired chemical product.
• C Flux Analysis: Isotopic labeling analysis and the most accurate computation of internal flux distributions for large scale metabolic networks.
• Wet Lab:
• Enhanced Evolutionary Engineering: Patented adaptive evolution of microbes to allow for rapid self-optimization for process conditions.
• High-Throughput Fermentation: Hundreds of small-scale fermentations per day.